Decisions of the Investment Committee on February 21, 2025

In accordance with Article 5 and based on Article 9, paragraphs 9.1 and 9.6 of Law No. 04/L-101, amended and supplemented by Law 04/L-115, Law 04/L-168, Law 05/L-116, and Law 07/L-016, as well as in accordance with Article 13, Article 33, and paragraph 1 of Article 41 of the Statute of KPST, and with the Statement of Investment Principles (SIP), the Investment Committee of the KPST Governing Board, on February 21, 2025, made the following decisions:

1. To engage the funds selected according to the public invitation for multi-assets IC/2024/04:

• Allianz Dynamic Muti Asset Strategy SRI (with ISIN: LU2093606593).
• Blackrock Global Allocation Fund (with ISIN: LU1653088838).
• Schroder Global Multi-Asset Balanced (with ISIN: LU0776414590).

2. To engage the funds selected according to the public invitation for active funds IC/2024/02:

• JP Morgan Global Select Equity (with ISIN: LU2552654589).
• Schroder Global Equity-Alpha (with ISIN: LU0248167297).

3. In the Standard Portfolio, tactically invest in Nasdaq QQQ ETF up to 80 million euros, in three tranches (40+20+20 million euros), if the set conditions of the unit price are reached.

4. Investments from point 3. can be sold if the price of the fund (Nasdaq QQQ ETF) returns to the previous peak.

5. To invest 30 million euros in BNP Paribas Healthcare Innovators (ISIN: LU0823417067) of which:

– 26 million euros in the Standard Portfolio and

– 4 million euros in the Intermediate Portfolio, following changes to the SIP by the Board of Directors.

6. Version 1.2 of the Asset Allocation Strategy is approved.